Pure Bioscience, Inc. (PURE) Reports Q2 Loss of $0.05

Pure Bioscience, Inc. (NASDAQ: PURE) reported Q2 EPS of ($0.05), versus ($0.07) reported last year. Revenue for the quarter came in at $221 thousand, versus $68 thousand reported last year.

For earnings history and earnings-related data on Pure Bioscience, Inc. (PURE) click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• JPMorgan Upgrades Aviva Plc (AV/:LN) (AIVAF) to Overweight
• Morgan Stanley Upgrades Oil India Ltd. (OINL:IN) to Equalweight
• Citi sees Birkenstock EPS beat, guidance lift on FX and lower share count